More on BMY

- Summary
- Chart
- Profile
- Historical


- Earnings
- Ratings
- Holders
- Dividends


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/24/2014)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

BMY Balance Sheet

Click line-items for a historical chart and %
Current Assets:
Cash and cash equivalents 4.28B
Marketable securities 2.89B
Receivables 3.32B
Inventories 1.67B
Deferred income taxes 1.36B
Prepaid expenses and other 512M
Total Current Assets 14.06B
Property, plant and equipment 4.44B
Goodwill 7.05B
Other intangible assets 1.84B
Deferred income taxes 875M
Marketable securities 3.88B
Other assets 1.36B
Total Assets 33.5B
Current Liabilities:
Short-term borrowings 365M
Accounts payable 2.41B
Accrued expenses 2.2B
Deferred income 1.09B
Accrued rebates and returns 909M
U.S. and foreign income taxes payable 204M
Dividends payable 621M
Total Current Liabilities 7.8B
Pension, postretirement, and postemployment liabilities 681M
Deferred income 1.04B
U.S. and foreign income taxes payable 545M
Other liabilities 624M
Long-term debt 7.37B
Total Liabilities 18.12B
Commitments and contingencies (Note 14) 0
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 5,268 in 2011 and 5,269 in 2010, liquidation value of $50 per share 0
Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2011 and 2010 221M
Capital in excess of par value of stock 1.48B
Accumulated other comprehensive loss -2.23B
Retained earnings 33.03B
Less cost of treasury stock - 500 million common shares in 2011 and 501 million in 2010 -17.17B
Total Bristol-Myers Squibb Company Shareholders' Equity 15.33B
Noncontrolling interest 52M
Total Equity 15.38B
Total Liabilities and Equity 33.5B